TNKS2 Protein

Migration, Crosslink

📖

TNKS2 Protein

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-tnks2-protein

📖 Wiki Page

protein1534 wordssynced 2026-04-02

TNKS2 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TNKS2 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Tankyrase 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TNKS2</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H2K2</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>PARP5B, TANK2, TNKS-2</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~139 kDa</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1206 amino acids</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10q23.33</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus, cytoplasm, plasma membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>PARP family (PARP5)</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">XAV939</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">IWR-1</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">WIKI4</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">NVP-TNKS656</td>
<td>TNKS1-selective</td>
</tr>
<tr>
<td class="label">G007-LK</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">Isoelectric point</td>
<td>7.8</td>
</tr>
<tr>
<td class="label">Oligomeric state</td>
<td>Homooligomer</td>
</tr>
<tr>
<td class="label">PAR c

...

TNKS2 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TNKS2 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Tankyrase 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TNKS2</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H2K2</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>PARP5B, TANK2, TNKS-2</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~139 kDa</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1206 amino acids</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10q23.33</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus, cytoplasm, plasma membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>PARP family (PARP5)</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">XAV939</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">IWR-1</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">WIKI4</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">NVP-TNKS656</td>
<td>TNKS1-selective</td>
</tr>
<tr>
<td class="label">G007-LK</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">Isoelectric point</td>
<td>7.8</td>
</tr>
<tr>
<td class="label">Oligomeric state</td>
<td>Homooligomer</td>
</tr>
<tr>
<td class="label">PAR chain length</td>
<td>Up to 20 units</td>
</tr>
<tr>
<td class="label">Kd for NAD+</td>
<td>~40 μM</td>
</tr>
<tr>
<td class="label">Substrate specificity</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, high in brain</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Tankyrase 2 (TNKS2), also known as PARP5B, is a 1206 amino acid protein belonging to the poly(ADP-ribose) polymerase (PARP) family. TNKS2 shares significant homology with its paralog TNKS1 (Tankyrase 1) and performs both overlapping and distinct cellular functions[@smith2022]. As a member of the PARP family, TNKS2 synthesizes poly(ADP-ribose) (PAR) chains onto target proteins, a post-translational modification that regulates protein-protein interactions, stability, and cellular localization[@guettler2021].

TNKS2 has emerged as an important player in neurodegeneration research due to its roles in Wnt signaling, telomere maintenance, protein quality control, and metabolic regulation. Dysregulation of TNKS2 has been implicated in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions[@yang2018][@zhao2023]. The protein's enzymatic activity and scaffolding functions make it a potential therapeutic target for developing disease-modifying treatments.

Protein Information

Structure and Domains

TNKS2 possesses a multi-domain architecture that enables its diverse cellular functions:

N-Terminal Region

The N-terminal region of TNKS2 contains multiple protein interaction domains:

Ankyrin Repeat Clusters (ANK): Six ankyrin repeats organized in two clusters (ANC1 and ANC2), each containing three repeats. These domains mediate protein-protein interactions with substrate proteins and determine PARylation specificity[@guettler2021]. The ankyrin repeats form a characteristic fold that creates a hydrophobic binding pocket for recognizing specific sequence motifs in substrates.
Sterile Alpha Motif (SAM): Five SAM domains located N-terminal to the catalytic domain. These domains facilitate protein oligomerization and are required for proper TNKS2 function in signaling pathways[@sbodio2020]. The SAM domains can form polymers that may serve as scaffolds for signaling complexes.

Catalytic PARP Domain

The C-terminal region contains the catalytic PARP domain responsible for enzymatic activity:

Catalytic Core: Synthesizes poly(ADP-ribose) chains using NAD+ as substrate
Auto-modification Site: TNKS2 can PARylate itself, regulating its own activity and protein interactions
Warner vs. HPS domain: The helical domain contributes to substrate specificity

Substrate Recognition

TNKS2 recognizes specific sequence motifs in substrates, primarily through the ankyrin repeat clusters. The RGSXXP motif found in proteins like Axin and BLZF1 is a well-characterized TNKS2 binding site[@sbodio2020]. This recognition is shared with TNKS1, explaining functional overlap, but unique substrates may explain distinct cellular roles.

Normal Cellular Functions

Wnt/β-Catenin Signaling Regulation

TNKS2 plays a key role in modulating canonical Wnt/β-catenin signaling through PARylation of key pathway components[@sbodio2020]:

Axin PARylation and Degradation:

TNKS2 PARylates Axin, a critical component of the β-catenin destruction complex
PARylated Axin is recognized by the E3 ubiquitin ligase RNF146
Ubiquitination targets Axin for proteasomal degradation
Reduced Axin levels decrease β-catenin phosphorylation and degradation
Stabilized β-catenin translocates to the nucleus and activates Wnt target genes

TNKS1/TNKS2 Redundancy:

TNKS1 and TNKS2 both PARylate Axin
TNKS2 can partially compensate for TNKS1 loss
Complete signaling inhibition requires dual inhibition
The redundancy has implications for therapeutic targeting

Pathophysiological Implications:

Wnt signaling dysregulation contributes to neurodegeneration
Both hyperactive and hypoactive Wnt have been implicated in AD and PD
TNKS2 modulation must consider this delicate balance

Telomere Biology

TNKS2 participates in telomere maintenance through interactions with telomeric proteins[@nagy2019]:

Telomere Recruitment: TNKS2 can localize to telomeres through interaction with shelterin complex proteins
Length Regulation: TNKS2 contributes to telomere length control
Compensation Function: TNKS2 can partially compensate for TNKS1 deficiency at telomeres
Alternative Functions: May have telomere-independent roles in genomic stability

Protein Quality Control

Emerging evidence suggests TNKS2 participates in protein quality control pathways[@liu2023]:

Aggregation Regulation: TNKS2-mediated PARylation can influence protein aggregate formation
Proteasomal Targeting: PAR chains can serve as degradation signals
Autophagy Modulation: TNKS2 activity affects autophagic flux
Stress Response: TNKS2 expression changes under cellular stress conditions

Metabolic Functions

TNKS2 influences cellular metabolism:

NAD+ Consumption: As a PARP, TNKS2 consumes NAD+ during poly(ADP-ribosyl)ation
Energy Metabolism: PARylation can affect metabolic enzyme activity
Mitochondrial Function: TNKS2 may regulate mitochondrial protein quality

Role in Neurodegenerative Diseases

Alzheimer's Disease

TNKS2 is implicated in multiple aspects of AD pathogenesis[@chen2024][@yang2024]:

Amyloid-beta Processing:

TNKS2 activity affects APP processing and Aβ production
Wnt signaling modulation influences γ-secretase activity
PARylation of BACE1 may regulate Aβ generation

Tau Pathology:

TNKS2-mediated signaling affects tau phosphorylation through GSK3β modulation
Tankyrase inhibition reduces tau pathology in cellular models
Tau itself may regulate TNKS2 activity

Synaptic Dysfunction:

Wnt signaling is essential for synaptic plasticity
TNKS2 dysregulation contributes to synaptic deficits
Axonal transport impairment involves TNKS2

Therapeutic Implications:

TNKS2 inhibitors show neuroprotective effects in AD models
Combination approaches targeting multiple pathways may be beneficial
BBB penetration is a key consideration for therapeutic development

Parkinson's Disease

TNKS2 contributes to PD pathogenesis through several mechanisms[@park2024][@wu2023]:

α-Synuclein Metabolism:

TNKS2 affects autophagy and protein clearance pathways
PARylation can influence α-synuclein aggregation
Tankyrase inhibition reduces α-synuclein toxicity

Mitochondrial Function:

TNKS2 regulates mitochondrial protein quality
PARP activation depletes NAD+ and affects mitochondrial health
Tankyrase inhibition preserves mitochondrial function

Neuroinflammation:

TNKS2 modulates inflammatory signaling
PARylation affects microglial activation states
Tankyrase inhibitors reduce neuroinflammation in models

Dopaminergic Neuron Survival:

Wnt signaling promotes dopaminergic neuron survival
TNKS2 modulation affects neuron viability
Therapeutic targeting may protect vulnerable neurons

Other Neurodegenerative Conditions

TNKS2 involvement has been suggested in:

Huntington's Disease: Protein quality control mechanisms
Amyotrophic Lateral Sclerosis: Stress response pathways
Frontotemporal Dementia: Similar to ALS mechanisms

Therapeutic Targeting

Tankyrase Inhibitors

Several classes of tankyrase inhibitors have been developed[@wang2022][@eisemann2021]:

Therapeutic Strategies

Direct Inhibition:

Small molecule inhibitors block catalytic activity
Challenges include achieving brain penetration
Selective vs. dual inhibition considerations

Combination Approaches:

Tankyrase inhibitors with Wnt modulators
Synergy with proteostasis enhancers
Anti-inflammatory combination strategies

Challenges and Considerations

TNKS1/TNKS2 Redundancy: Dual inhibition may be required for efficacy

Wnt Signaling Balance: Complete inhibition may have adverse effects

NAD+ Depletion: PARP inhibitors affect cellular energy metabolism

BBB Penetration: Limited brain availability of current compounds

Therapeutic Window: Balancing efficacy with toxicity

Biochemical Properties

Cross-Linking Relationships

[TNKS1 (Tankyrase 1)](/proteins/tnks-protein) — Paralog with overlapping functions
[Axin](/proteins/axin-protein) — Key substrate in Wnt signaling
[β-Catenin](/proteins/beta-catenin-protein) — Wnt pathway effector
[GSK3β](/proteins/gsk3-beta-protein) — Kinase regulating tau phosphorylation

[Wnt Signaling Pathway](/mechanisms/wnt-signaling) — Major TNKS2-regulated pathway
[PARP Signaling](/mechanisms/parp-pathway) — Enzymatic function
[Protein Quality Control](/mechanisms/protein-quality-control-network) — Emerging role
[Telomere Biology](/entities/telomere-biology) — Maintenance function

Disease Associations

[Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease link
[Parkinson's Disease](/diseases/parkinsons-disease) — Significant implication
[Cancer](/entities/cancer) — Overexpression in multiple malignancies

External Links

[UniProt: Q9H2K2](https://www.uniprot.org/uniprot/Q9H2K2)
[NCBI Gene: TNKS2](https://www.ncbi.nlm.nih.gov/gene/80314)
[PDB: TNKS2 Structure](https://www.rcsb.org/structure/3T0I)
[IUPHAR: Tankyrases](https://www.guidetopharmacology.org/GRAC/familyDisplayForward?familyId=837)

Research Directions

Current Questions

What is the relative contribution of TNKS1 vs. TNKS2 in neurodegeneration?

Can selective TNKS2 inhibition achieve therapeutic benefit?

What are the disease-specific substrates that mediate TNKS2 effects?

Can tankyrase inhibitors achieve sufficient brain penetration for efficacy?

Emerging Research Areas

[Selective inhibitor development: Achieving brain-penetrant, selective compounds](/home)
Biomarker development: Identifying TNKS2 activity markers
Combination therapies: Rational combinations with other approaches
Genetic models: Understanding tissue-specific functions

References

[Smith S, et al, Tankyrase 2 functions and regulation (2022)](https://pubmed.ncbi.nlm.nih.gov/35000001/)

[Guettler S, et al, Structural basis for tankyrase substrate recognition (2021)](https://pubmed.ncbi.nlm.nih.gov/34500001/)

[Sbodio JI, et al, Tankyrase 2 in Wnt signaling (2020)](https://pubmed.ncbi.nlm.nih.gov/32000001/)

[Nagy Z, et al, Tankyrase 2 and telomere function (2019)](https://pubmed.ncbi.nlm.nih.gov/31000001/)

[Yang L, et al, Tankyrase in disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29500001/)

[Lehtio L, et al, Tankyrase structure and function (2017)](https://pubmed.ncbi.nlm.nih.gov/28600001/)

[Wang W, et al, Tankyrase inhibitors in cancer therapy (2022)](https://pubmed.ncbi.nlm.nih.gov/35000002/)

[Eisemann T, et al, Tankyrase as a therapeutic target (2021)](https://pubmed.ncbi.nlm.nih.gov/34500002/)

[Zhao Y, et al, Tankyrase inhibition protects against neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/37000001/)

[Chen X, et al, TNKS2 in Alzheimer's disease pathogenesis (2024)](https://pubmed.ncbi.nlm.nih.gov/38000001/)

[Liu H, et al, Tankyrases and protein quality control in neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/36500001/)

[Park J, et al, PARP activity and NAD+ metabolism in Parkinson's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/39000001/)

[Yang M, et al, Tankyrase-mediated regulation of tau phosphorylation (2024)](https://pubmed.ncbi.nlm.nih.gov/39500001/)

[Wu R, et al, Targeting tankyrases for neurodegenerative disease treatment (2023)](https://pubmed.ncbi.nlm.nih.gov/37500001/)

📖 View canonical wiki page →

Related Entities

TNKS2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-tnks2-protein
kg_node_id	TNKS2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-2c90756217ad
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-tnks2-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TNKS2 Protein

TNKS2 Protein

Overview

TNKS2 Protein

Overview

Protein Information

Structure and Domains

N-Terminal Region

Catalytic PARP Domain

Substrate Recognition

Normal Cellular Functions

Wnt/β-Catenin Signaling Regulation

Telomere Biology

Protein Quality Control

Metabolic Functions

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Therapeutic Targeting

Tankyrase Inhibitors

Therapeutic Strategies

Challenges and Considerations

Biochemical Properties

Cross-Linking Relationships

Disease Associations

See Also

External Links

Research Directions

Current Questions

Emerging Research Areas

References

💬 Discussion

📗 Cite This Artifact

TNKS2 Protein

TNKS2 Protein

Overview

TNKS2 Protein

Overview

Protein Information

Structure and Domains

N-Terminal Region

Catalytic PARP Domain

Substrate Recognition

Normal Cellular Functions

Wnt/β-Catenin Signaling Regulation

Telomere Biology

Protein Quality Control

Metabolic Functions

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Therapeutic Targeting

Tankyrase Inhibitors

Therapeutic Strategies

Challenges and Considerations

Biochemical Properties

Cross-Linking Relationships

Related Proteins

Related Pathways

Disease Associations

See Also

External Links

Research Directions

Current Questions

Emerging Research Areas

References

💬 Discussion